MITF and melanoma: Key to understanding phenotype‐switching in melanoma is the microphthalmia‐associated transcription factor MITF (Goding & Arnheiter, 2019), first identified because of its critical role in promoting survival of migrating melanoblasts in development (Hodgkinson et al., 1993).